Q-omics provides the consensus-scored RNU6-1225P profile across patient tissues and cancer cell-line models. RNU6-1225P expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LUSC. Additionally, RNU6-1225P RNA expression shows 9,920 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight LUSC, and GBM as cancer lineages where RNU6-1225P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-1225P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-1225P survival associations across molecular data types. RNU6-1225P RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-1225P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	8	LUSC (87)	view →

This table ranks reproducible RNU6-1225P RNA expression–survival associations across cancer types. High RNU6-1225P expression shows unfavorable associations in LUSC, PAAD, KIRC, KIRP, COAD and ESCA. The LUSC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify LUSC as the clearest survival context for RNU6-1225P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	II,III,IV	0.289	0.737	.001	87	view →
PAAD	OS	Tertile	II,III,IV	0.232	0.561	<.001	36	view →
KIRC	DFS	Tertile	IV	0.173	0.624	.005	36	view →
KIRP	OS	Tertile	II,III,IV	0.180	0.771	.007	27	view →
COAD	OS	Tertile	II,III,IV	0.320	0.796	.006	18	view →
ESCA	DFS	Median	II,III,IV	0.418	0.889	.042	15	view →

Pink = unfavorable, green = favorable. all 8 lineages →

RNU6-1225P-LUSC (OS)

Kaplan–Meier survival curve for RNU6-1225P RNA expression in LUSC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-1225P in patient tissues and cancer cell lines. In patient samples, RNU6-1225P shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	9,920	GBM (4369)	view →
RNA	8,133	COAD (2512)	view →